BetterLife Pharma (BETRF) Net Income towards Common Stockholders Growth (5y) (2016 - 2026)
BetterLife Pharma (BETRF) Net Income towards Common Stockholders Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 25.01% |
| Jul 31, 2025 | 20.46% |
| Apr 30, 2025 | -74.35% |
| Apr 30, 2024 | 6.22% |
| Oct 31, 2023 | 36.66% |
| Jul 31, 2023 | 16.53% |
| Apr 30, 2023 | 21.36% |
| Jan 31, 2023 | -23.97% |
| Jul 31, 2022 | -27.75% |
| Apr 30, 2022 | -51.64% |
| Jan 31, 2022 | -30.25% |
| Oct 31, 2021 | -20.41% |
| Jul 31, 2021 | -19.76% |
| Apr 30, 2021 | 10.87% |
| Jan 31, 2021 | -32.87% |
| Jul 31, 2017 | -2,934.08% |
| Apr 30, 2017 | -2,613.65% |
| Jan 31, 2017 | -2,979.01% |
| Jul 31, 2016 | -4,014.64% |
| Apr 30, 2016 | -3,439.21% |